Germany will become "biotechnology capital of Europe", science minister tells conference
This article was originally published in Clinica
Executive Summary
"Biotechnology is booming in Germany. We are on course to become Europe's top biotech location. Germany has the best conditions for new companies, for research and for production." This was the view of Dr Jurgen Ruttgers, the German Minister for Education, Science, Research and Technology, speaking at the Bio '98 international biotechnology meeting and exhibition in New York this month.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.